Masimo has been granted a patent for a medical system that includes a patient monitoring device, a patient information system, and a mobile application. This system enables monitoring of physiological parameters, facilitates communication between patients and clinicians, and provides tools for managing schedules and medication compliance. GlobalData’s report on Masimo gives a 360-degree view of the company including its patenting strategy. Buy the report here.
According to GlobalData’s company profile on Masimo, Medical data analysis was a key innovation area identified from patents. Masimo's grant share as of June 2024 was 59%. Grant share is based on the ratio of number of grants to total number of patents.
Patient monitoring system with clinician communication and compliance tracking
The granted patent US12042245B2 outlines a comprehensive medical system designed to enhance patient monitoring and clinician communication. Central to this system is a patient monitoring device that tracks various physiological parameters and is integrated with a patient information system. This system features a mobile application that facilitates real-time communication between clinicians and patients, allowing clinicians to receive, view, and send information related to the patient's health. Notably, the patient information system displays the patient's schedule and includes compliance inputs for patients to indicate adherence to scheduled items. Additionally, it features a graphical compliance indicator that visually represents the patient's adherence to their schedule.
Further enhancements to the system include a communications application that enables text and voice interactions between patients and clinicians, along with preset notification inputs for streamlined communication. The design incorporates visual prominence for these notifications based on their usage frequency, allowing for personalized interactions. The patient monitoring device may also include a camera for video calls, while the patient information system provides comprehensive details such as medication schedules, upcoming procedures, and clinician contact information. The graphical compliance indicator can display various states of completion, providing patients with visual feedback on their adherence to treatment plans. Overall, this patent presents a multifaceted approach to improving patient engagement and compliance through technology-driven solutions.
To know more about GlobalData’s detailed insights on Masimo, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.